Ibrutinib RESONATE Data Show Significant Improvements in Progression-Free Survival and Overall Survival in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- EMEA Innovative Medicine
- Ibrutinib Data: Significant Improvements in Survival of CLL and SLL Patients
Ibrutinib Data: Significant Improvements in Survival of CLL and SLL Patients
- X (Twitter)
Copy link